SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-22-067068
Filing Date
2022-06-01
Accepted
2022-06-01 14:54:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm2217490-1_sc13ga.htm SC 13G/A 47735
  Complete submission text file 0001104659-22-067068.txt   49072
Mailing Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017
Business Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017 212-588-0022
Q BioMed Inc. (Subject) CIK: 0001596062 (see all company filings)

IRS No.: 464013793 | State of Incorp.: NV | Fiscal Year End: 1130
Type: SC 13G/A | Act: 34 | File No.: 005-89881 | Film No.: 22987043
SIC: 2834 Pharmaceutical Preparations

Mailing Address 366 MADISON AVENUE, 3RD FLOOR NEW YORK NY 10017
Business Address
Jatwes Ari (Filed by) CIK: 0001814776 (see all company filings)

Type: SC 13G/A